Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Adult and Adolescent Subjects

Trial Profile

Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Adult and Adolescent Subjects

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 16 Jun 2017

At a glance

  • Drugs Macitentan (Primary)
  • Indications Heart disorders
  • Focus Registrational; Therapeutic Use
  • Acronyms RUBATO
  • Sponsors Actelion Pharmaceuticals
  • Most Recent Events

    • 08 Jun 2017 Planned End Date changed from 23 Jan 2020 to 14 Feb 2020.
    • 08 Jun 2017 Planned primary completion date changed from 17 Jan 2020 to 14 Feb 2020.
    • 08 Jun 2017 Planned initiation date changed from 10 Aug 2017 to 15 Aug 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top